Care
Venture capital and private equity firm Insight Partners led the round with participation from existing investors including Equity Group Investments.
TRIPP PsyAssist will provide protocols and anxiety-easing support to patients undergoing ketamine-assisted therapy.
The pharmacists argue the partnership will hurt independent pharmacies and hides the real issues behind high drug costs.
The app may have been expanded to consumers if it had been successful internally, according to Insider.
Big Health CEO Peter Hames discusses how apps like his are changing therapy.
Facebook removed a slew of pages, groups and accounts for spreading COVID-19 vaccine misinformation on its platforms.
The menopause market opportunity has been valued at $600B, and investors are starting to notice innovators.
They created a classification algorithm that can determine whether a COVID-19 patient is likely to suffer from severe symptoms.
It also supplies enrolled employees with a free TRX Suspension Trainer, discounts on other TRX products and a complimentary one-on-one virtual training introduction session.
Also: Opya scooped up $15.4 million, MiSalud raised $5 million and DocSpace announced $1.2 million in seed funding.